Cargando…
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment
Harnessing immune effector cells to benefit cancer patients is becoming more and more prevalent in recent years. However, the increasing number of different therapeutic approaches, such as chimeric antigen receptors and armored chimeric antigen receptors, requires constant adjustments of the transge...
Autores principales: | Greenshpan, Yariv, Sharabi, Omri, Yegodayev, Ksenia M., Novoplansky, Ofra, Elkabets, Moshe, Gazit, Roi, Porgador, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266962/ https://www.ncbi.nlm.nih.gov/pubmed/35806439 http://dx.doi.org/10.3390/ijms23137431 |
Ejemplares similares
-
Synthetic promoters to induce immune-effectors into the tumor microenvironment
por: Greenshpan, Yariv, et al.
Publicado: (2021) -
High throughput screen for the improvement of inducible promoters for tumor microenvironment cues
por: Sharabi, Omri, et al.
Publicado: (2022) -
Developing a dual VEGF/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy
por: Tzuri, Noam, et al.
Publicado: (2023) -
TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer
por: Yegodayev, Ksenia M., et al.
Publicado: (2020) -
Worldwide Prevalence and Clinical Characteristics of RAS Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis
por: Novoplansky, Ofra, et al.
Publicado: (2022)